C07D 277/24
Radicals substituted by oxygen atoms
C07D277/24 (Radicals substituted by oxygen atoms) appears on 825 US grants and 687 published applications in this corpus.
Search patents in C07D- Granted patents
- 825
- Published applications
- 687
- Assignees
- 403
- Inventors
- 2,514
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 5 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 9 | 0 |
| 1990 | 12 | 0 |
| 1991 | 15 | 0 |
| 1992 | 15 | 0 |
| 1993 | 19 | 0 |
| 1994 | 14 | 0 |
| 1995 | 18 | 0 |
| 1996 | 21 | 0 |
| 1997 | 35 | 0 |
| 1998 | 26 | 0 |
| 1999 | 23 | 0 |
| 2000 | 19 | 0 |
| 2001 | 29 | 6 |
| 2002 | 29 | 25 |
| 2003 | 29 | 57 |
| 2004 | 29 | 54 |
| 2005 | 25 | 53 |
| 2006 | 34 | 33 |
| 2007 | 29 | 33 |
| 2008 | 23 | 36 |
| 2009 | 22 | 34 |
| 2010 | 32 | 46 |
| 2011 | 26 | 31 |
| 2012 | 35 | 28 |
| 2013 | 29 | 32 |
| 2014 | 29 | 32 |
| 2015 | 30 | 23 |
| 2016 | 23 | 24 |
| 2017 | 13 | 21 |
| 2018 | 11 | 20 |
| 2019 | 17 | 11 |
| 2020 | 7 | 12 |
| 2021 | 9 | 18 |
| 2022 | 13 | 13 |
| 2023 | 9 | 14 |
| 2024 | 7 | 15 |
| 2025 | 10 | 9 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Arylamides and methods of use thereof19 May 2026US 12,630,498 B2Genzyme Corporation
- Carboxy derivatives with antiinflamatory properties5 May 2026US 12,617,762 B2Sitryx Therapeutics Limited
- Cyclopentenones derivatives and their use as antibiotics28 Apr 2026US 12,612,354 B2Centre National de la Recherche Scientifique (CNRS)
- Hepatitis B antiviral agents16 Dec 2025US 12,496,282 B2Enanta Pharmaceuticals, Inc.
- Stacked organic electroluminescent device28 Oct 2025US 12,454,538 B2Beijing Summer Sprout Technology Co., Ltd.
- Novel indenone derivatives and uses thereof3 Sep 2026US 2026/0256797 A1Amyloid Solution Inc.
- Compounds with immunomodulatory activity and therapeutic uses thereof30 Jul 2026US 2026/0217665 A1Purdue Research Foundation
- Protease inhibitors for treating or preventing coronavirus infection23 Jul 2026US 2026/0209180 A1Merck Sharp & Dohme Corp.
- Ferroptosis inducers to treat cancer16 Jul 2026US 2026/0199297 A1The University of Toledo
- Novel five-membered heterocycle substituted styrene derivative, and preparation method therefor and use thereof16 Jul 2026US 2026/0200882 A1Guangzhou Nanocrystal Biotechnology Co., Ltd.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions103US 5,614,548 AWake Forest University · 1997
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996